ct3 Cancer Detections

No items found.

A finalist for the Startup Award, Lauren developed ct3, a wearable biosensor that detects circulating tumor DNA in sweat using microfluidics and spectroscopy, enabling non-invasive, real-time cancer monitoring. It merges oncology diagnostics with wearable tech to provide a low-cost, scalable alternative for early detection.

Current Needs

Investor
 / 10
Philantropists
 / 10
Customers
 / 10
Business Partner
 / 10
Advisor
 / 10

Info

Business model
Company Stage
Country
Canada

Top Challenges

No items found.

Team

Lauren Altomare

More projects with the same SDGS